| EP3337828 - ANTI-PCSK9 INHIBITORY ANTIBODIES FOR TREATING PATIENTS WITH HYPERLIPIDEMIA UNDERGOING LIPOPROTEIN APHERESIS [Right-click to bookmark this link] | Status | Unitary effect registered Database last updated on 08.04.2026 | |
| Former | Request for unitary effect filed Status updated on 24.09.2025 | Most recent event Tooltip | 20.02.2026 | Change or deletion: representative for unitary effect | published on 25.03.2026 [2026/13] | Proprietor(s) | For all participating member states Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | [2025/44] | Inventor(s) | 01 /
PORDY, Robert C. c/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road Tarrytown, New York 10591 / US | 02 /
MANVELIAN, Garen c/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road Tarrytown, New York 10591 / US | [2018/26] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [2026/13] |
| Former [2026/08] | Kilburn & Strode LLP Lacon London 84 Theobalds Road Holborn London WC1X 8NL / GB | ||
| Former [2025/44] | Mackie, Heather, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | Application number, filing date | 16758019.0 | 17.08.2016 | [2018/26] | WO2016US47257 | Procedural language | EN | (Principal) place of business Tooltip on the date of filing | Principal place of businessTooltip | Unitary Patent Protection | 23.09.2025 | Date of request for unitary effect [2025/44] | 30.09.2025 | Decision on the request for unitary effect: Positive [2025/44] | 30.09.2025 | Date of registration [2025/44] | 27.08.2025 | Date of legal effect [2025/44] | Member States covered by Unitary Tooltip Patent Protection | 30.09.2025 | AT, BE, BG, DE, DK, EE, FI, FR, IT, LT, LU, LV, MT, NL, PT, RO, SE, SI [2025/44] | Publication | Type: | B1 Patent specification | No.: | EP3337828 | Date: | 27.08.2025 | Language: | EN | [2025/35] |